TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ).
Sinco Pharmaceuticals Holdings Ltd. has announced its upcoming annual general meeting scheduled for May 15, 2025, in Kunming City, China. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, re-appointment of auditors, and approval of a final dividend. These resolutions are expected to impact the company’s governance and financial strategies, potentially influencing shareholder value and market perception.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is incorporated under the laws of the Cayman Islands and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -10.50%
Average Trading Volume: 540,071
Technical Sentiment Signal: Buy
Current Market Cap: HK$363.9M
See more insights into 6833 stock on TipRanks’ Stock Analysis page.